Impact of Pre-transplant Therapy and Depth of Disease Response prior to Autologous Transplantation for Multiple Myeloma

Patients with multiple myeloma (MM), who are eligible for autologous stem cell transplantation (ASCT), typically receive a finite period of initial therapy prior to ASCT. It is not clear if patients with suboptimal (less than a partial) response to initial therapy benefit from additional alternative...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Vij, Ravi, Kumar, Shaji, Zhang, Mei-Jie, Zhong, Xiaobo, Huang, Jiaxing, Dispenzieri, Angela, Abidi, Muneer H., Bird, Jennifer M., Freytes, César O., Gale, Robert Peter, Kindwall-Keller, Tamila L., Kyle, Robert A., Landsburg, Daniel J., Lazarus, Hillard M., Munker, Reinhold, Roy, Vivek, Sharma, Manish, Vogl, Dan T., Wirk, Baldeep, Hari, Parameswaran N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297511/
https://ncbi.nlm.nih.gov/pubmed/25445028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi